Navigation Links
Royalty Pharma Statement Regarding Elan Proposal

ue by therapeutic areaTherapeutic AreaPercentRheumatology

31 percentHIV

18 percentOncology

13 percentDiabetes

11 percentNeurology

10 percentCardiology

8 percentAntibiotics

7 percentOther

2 percentAPPENDIX VI: Calculation of Current Enterprise Value and Proposal Enterprise ValueTable 3 - Enterprise Value (US$m unless stated)Current Enterprise
ValueProposal Enterprise
ValuePrice of Elan Stock

US$10.35[22]US$11.00Fully diluted number of Elan Stock outstanding (m) – Table 4


602.0Market capitalization


6,622.4Elan net cash – Table 5


3,061.5Enterprise value3,165.43,560.9% premium to Current Enterprise Value12.5% Table 4 – Fully diluted shares (m unless stated)Current Enterprise
ValueProposal Enterprise ValuePrice of Elan Stock


US$11.00Total voting rights[23]


595.3Dilution from options and restricted stock units[24]


6.7Fully diluted shares outstanding601.6602.0 Table 5 - Elan net cash position (US$m unless stated)Net cashCash and cash equivalents

431.3Proceeds from sale of Alkermes Shares[25]

169.7Restricted cash and cash equivalents —current

2.6Long-term debt

(600.0)Janssen AI funding commitment[26]

(123.1)Restructuring accruals

(27.6)Accrued transaction costs

(12.5)Cambridge Collaboration termination[27]

(8.0)Unfunded pension liability[28]

(39.1)Value of Prothena stake[29]

19.1Proceeds to come from Tysabri Transaction[30]

3,249.0Net cash pro forma for Tysabri Transaction3,061.5Note: Where not otherwise cited, figures are extracted from Elan's balance sh

SOURCE RP Management, LLC
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31

Related biology technology :

1. PDL BioPharma Provides Third Quarter 2012 Royalty Revenue Guidance of $85 Million
2. Cowen Healthcare Royalty Partners Raises $1 Billion
3. Array Biopharma and Global Blood Therapeutics Announce Drug Discovery Collaboration Focused on Hematology
4. Radiopharmaceuticals Market - Global Industry Analysis, Size, Share, Trends And Forecast, 2012 - 2018: MarketResearchReports.Biz
5. Alexandria Real Estate Equities, Inc. Announces Long-Term Lease with Leading Global Commercial-Stage Oncology Company, Onyx Pharmaceuticals, Inc., for New Build-to-Suit Facility in South San Francisco, California
6. AVANIR Pharmaceuticals To participate in two conferences in March
7. Favorable Scenario for Japan Pharma Industry in Coming Years, New Report Says
8. Hyperion Wins NDA Approval for UCD Drug Developed With Support from PharmaDirections
9. Technical Analysis on VIVUS and Achillion Pharma: Highlights on These Biotech Companies
10. Auxilium Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2012 Financial Results and Guidance for 2013
11. Serialization in Pharmaceuticals, a Webinar Presented by Xtalks
Post Your Comments:
(Date:10/9/2015)... ROCKVILLE, Md. , Oct. 9, ... biotechnology company developing next generation vaccines based on ... entered into an exclusive worldwide licensing agreement with ... treatment or prevention of any and all allergic ... Immunomic Therapeutics will receive an upfront payment of ...
(Date:10/9/2015)... CA (PRWEB) , ... October 09, 2015 , ... Leading ... study that aims to better understand the relationship between weight management and the microbiome. ... and more accurately from participants using an iPhone app. , The uBiome app is ...
(Date:10/8/2015)... 2015  Genetic testing for mutations beyond those currently ... more couples at risk of having a child with ... the 2015 American Society of Human Genetics (ASHG) Annual ... Baltimore, Maryland . The study is one of ... ) are presenting at the conference this week demonstrating ...
(Date:10/8/2015)... October 8, 2015 ... --> Goldman Small Cap Research, a ... cap and microcap sectors, announced today that it ... PharmaCyte Biotech, Inc. (OTCQB - PMCB), a publicly ... and preparing treatments for cancer and diabetes. To ...
Breaking Biology Technology:
... importance on ... indication-specific FDA approval, WALTHAM, Mass., April 2, 2008 ... into the marketing of biliary,stents for off-label uses in the ... could become a key focus for,stent manufacturers. A recent study ...
... 2008 Pharmaceutical,companies currently challenged with replacing the ... patent in the next four years must dramatically,rethink ... a new report,released by Deloitte today., According ... R&D in the Future,Pharmaceutical Landscape ( ), ...
... Amsterdam,Molecular Therapeutics (Euronext: AMT), a leader in ... AMT,s Supervisory Board has decided to,propose Dr. George ... at its,Annual General Meeting of shareholders on April ... retired as Senior Vice President of Development at,Amgen, ...
Cached Biology Technology:
(Date:9/28/2015)... JOSE, Calif. , Sept. 28, 2015 ... of human interface solutions, today announced that Lenovo has ... touch fingerprint sensor, FS4202, for its latest smartphone, the ... secure, password-free access to unlock the device and provide ... The feature-rich Natural ID FS4202 sensor ...
(Date:9/10/2015)... Sept. 10, 2015 This report provides detailed ... products today, and emerging sensor types that will dominate ... the peak of the wearable technology hype curve in ... disillusionment. The common feature with all of them is ... for their most useful functions. Sensors collect data about ...
(Date:9/10/2015)... -- NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or the ... mobile commerce market, announces that the San ... will feature the Wocket® smart wallet for the first ... Touch Of Modern is an online retailer ... its 7.2 million members. Customers are affluent, urban influencers ...
Breaking Biology News(10 mins):
... 2013) In what is anticipated to be a ... York Stem Cell Foundation (NYSCF) Research Institute is partnering ... Program (UDP). NYSCF scientists will generate stem cell ... with UDP researchers to better understand and potentially treat ...
... Huanglongbing (HLB) or citrus greening is a bacterial ... and poses a serious threat to the citrus industry. ... disrupting the trees, food transportation systems. To address ... rapidly characterize citrus varieties and hybrids and locate genes ...
... frogs and toads on national wildlife refuges. The rate of abnormalities ... overall indicating that the malformations first reported in the mid-1990s ... local "hotspots," suggesting that where these problems occur they have local ... PLOS ONE . "We now know what the baseline is ...
Cached Biology News:
Request Info...
TRIS-EDTA based buffer prepared from RNase-free water suitable for storage and dilution of siRNA, pH 8, store at 4 C ...
Request Info...
Biology Products: